Evidence map›Paper›PMID 32133987›Full record

ArticleActa crystallographica. Section D, Structural biology2020

SEQUENCE SLIDER: expanding polyalanine fragments for phasing with multiple side-chain hypotheses.

Rafael Junqueira Borges, Kathrin Meindl, Josep Triviño, Massimo Sammito, Ana Medina, Claudia Millán, Martin Alcorlo, Juan A Hermoso, Marcos Roberto de Mattos Fontes, Isabel Usón

Open access · hybridAbstract read
In one paragraph

Article in Acta crystallographica. Section D, Structural biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. ARCIMBOLDO at low resolution: Verification for coiled coils and globular proteins.Protein science : a publication of the Protein Society · 2024
    Article
  2. Article
  3. Modes and model building in SHELXE.Acta crystallographica. Section D, Structural biology · 2024
    Article
  4. Verification: model-free phasing with enhanced predicted models in ARCIMBOLDO_SHREDDER.Acta crystallographica. Section D, Structural biology · 2022
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Rafael Junqueira BorgesCrystallographic Methods, Institute of Molecular Biology of Barcelona (IBMB-CSIC), Baldiri Reixach 15, 08028 Barcelona, Spain.
Kathrin MeindlCrystallographic Methods, Institute of Molecular Biology of Barcelona (IBMB-CSIC), Baldiri Reixach 15, 08028 Barcelona, Spain.
Josep TriviñoCrystallographic Methods, Institute of Molecular Biology of Barcelona (IBMB-CSIC), Baldiri Reixach 15, 08028 Barcelona, Spain.
Massimo SammitoDepartment of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge CB2 0XY, England.
Ana MedinaCrystallographic Methods, Institute of Molecular Biology of Barcelona (IBMB-CSIC), Baldiri Reixach 15, 08028 Barcelona, Spain.
Claudia MillánCrystallographic Methods, Institute of Molecular Biology of Barcelona (IBMB-CSIC), Baldiri Reixach 15, 08028 Barcelona, Spain.ORCID 0000-0002-9283-2220
Martin AlcorloDepartment of Crystallography and Structural Biology, Instituto de Química-Física `Rocasolano', Consejo Superior de Investigaciones Científicas (CSIC), 28006 Madrid, Spain.
Juan A HermosoDepartment of Crystallography and Structural Biology, Instituto de Química-Física `Rocasolano', Consejo Superior de Investigaciones Científicas (CSIC), 28006 Madrid, Spain.
Marcos Roberto de Mattos FontesDepartamento de Física e Biofísica, Instituto de Biociências, Universidade Estadual Paulista (UNESP), Botucatu-SP 18618-689, Brazil.
Isabel UsónCrystallographic Methods, Institute of Molecular Biology of Barcelona (IBMB-CSIC), Baldiri Reixach 15, 08028 Barcelona, Spain.
Institut de Biologia Molecular de Barcelona · ESConsejo Superior de Investigaciones Científicas · ESUniversidade Estadual Paulista (Unesp) · BRUniversity of Cambridge · GB

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/24191-8Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/13485-3Generalitat de Catalunya 2017SGR-1192H2020 Marie Skłodowska-Curie Actions 790122Ministerio de Ciencia e Innovación 2017SGR-1192Ministerio de Ciencia e Innovación BFU2017-90030-PMinisterio de Ciencia e Innovación BIO2013-49604-EXPMinisterio de Ciencia e Innovación BIO2015-64216-PMinisterio de Ciencia e Innovación MDM2014-0435-01
6 · The paper itself

Abstract

Fragment-based molecular-replacement methods can solve a macromolecular structure quasi-ab initio. ARCIMBOLDO, using a common secondary-structure or tertiary-structure template or a library of folds, locates these with Phaser and reveals the rest of the structure by density modification and autotracing in SHELXE. The latter stage is challenging when dealing with diffraction data at lower resolution, low solvent content, high β-sheet composition or situations in which the initial fragments represent a low fraction of the total scattering or where their accuracy is low. SEQUENCE SLIDER aims to overcome these complications by extending the initial polyalanine fragment with side chains in a multisolution framework. Its use is illustrated on test cases and previously unknown structures. The selection and order of fragments to be extended follows the decrease in log-likelihood gain (LLG) calculated with Phaser upon the omission of each single fragment. When the starting substructure is derived from a remote homolog, sequence assignment to fragments is restricted by the original alignment. Otherwise, the secondary-structure prediction is matched to that found in fragments and traces. Sequence hypotheses are trialled in a brute-force approach through side-chain building and refinement. Scoring the refined models through their LLG in Phaser may allow discrimination of the correct sequence or filter the best partial structures for further density modification and autotracing. The default limits for the number of models to pursue are hardware dependent. In its most economic implementation, suitable for a single laptop, the main-chain trace is extended as polyserine rather than trialling models with different sequence assignments, which requires a grid or multicore machine. SEQUENCE SLIDER has been instrumental in solving two novel structures: that of MltC from 2.7 Å resolution data and that of a pneumococcal lipoprotein with 638 residues and 35% solvent content.

Indexed as

SoftwareAlgorithmsCrystallography, X-RayGlycosyltransferasesLipoproteinsPeptide FragmentsPeptidesProtein FoldingProtein Structure, SecondaryGlycosyltransferasesLipoproteinsPeptide FragmentsPeptidespolyalanineARCIMBOLDOfragment-based molecular replacementmolecular replacementPhaserphasingSEQUENCE SLIDERSHELXEside-chain extension

Identifiers

PMID32133987
PMCPMC7057211
OpenAlexW3009917996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.